Annual Non Current Assets
$986.85 M
-$115.65 M-10.49%
31 December 2023
Summary:
Halozyme Therapeutics annual long term assets is currently $986.85 million, with the most recent change of -$115.65 million (-10.49%) on 31 December 2023. During the last 3 years, it has risen by +$961.69 million (+3822.28%). HALO annual non current assets is now -10.49% below its all-time high of $1.10 billion, reached on 31 December 2022.HALO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$991.05 M
+$9.40 M+0.96%
30 September 2024
Summary:
Halozyme Therapeutics quarterly long term assets is currently $991.05 million, with the most recent change of +$9.40 million (+0.96%) on 30 September 2024. Over the past year, it has dropped by -$22.60 million (-2.23%). HALO quarterly non current assets is now -20.04% below its all-time high of $1.24 billion, reached on 30 June 2022.HALO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | -2.2% |
| 3 y3 years | +3822.3% | +489.5% |
| 5 y5 years | +7859.1% | +3400.1% |
HALO Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.5% | +3822.3% | -20.0% | +489.5% |
| 5 y | 5 years | -10.5% | +7859.1% | -20.0% | +4316.9% |
| alltime | all time | -10.5% | -20.0% |
Halozyme Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $991.05 M(+1.0%) |
| June 2024 | - | $981.66 M(+1.4%) |
| Mar 2024 | - | $967.94 M(-1.9%) |
| Dec 2023 | $746.42 M(+1.0%) | $986.85 M(-2.6%) |
| Sept 2023 | - | $1.01 B(-3.0%) |
| June 2023 | - | $1.04 B(-3.7%) |
| Mar 2023 | - | $1.08 B(-1.6%) |
| Dec 2022 | $739.01 M(-20.2%) | $1.10 B(-9.0%) |
| Sept 2022 | - | $1.21 B(-2.3%) |
| June 2022 | - | $1.24 B(+614.1%) |
| Mar 2022 | - | $173.56 M(-2.6%) |
| Dec 2021 | $926.29 M(+67.0%) | $178.14 M(+6.0%) |
| Sept 2021 | - | $168.12 M(+543.8%) |
| June 2021 | - | $26.11 M(+5.0%) |
| Mar 2021 | - | $24.86 M(-1.2%) |
| Dec 2020 | $554.76 M(+2.1%) | $25.16 M(+0.1%) |
| Sept 2020 | - | $25.13 M(-5.6%) |
| June 2020 | - | $26.64 M(+9.3%) |
| Mar 2020 | - | $24.38 M(+8.7%) |
| Dec 2019 | $543.44 M(+27.0%) | $22.44 M(-20.8%) |
| Sept 2019 | - | $28.32 M(+8.4%) |
| June 2019 | - | $26.12 M(+30.1%) |
| Mar 2019 | - | $20.07 M(+61.9%) |
| Dec 2018 | $427.85 M(-16.2%) | $12.40 M(-15.0%) |
| Sept 2018 | - | $14.58 M(+14.6%) |
| June 2018 | - | $12.72 M(+15.7%) |
| Mar 2018 | - | $11.00 M(+14.9%) |
| Dec 2017 | $510.37 M(+99.0%) | $9.57 M(+151.7%) |
| Sept 2017 | - | $3.80 M(-3.7%) |
| June 2017 | - | $3.95 M(-10.4%) |
| Mar 2017 | - | $4.41 M(-11.4%) |
| Dec 2016 | $256.53 M(+49.3%) | $4.98 M(-49.6%) |
| Sept 2016 | - | $9.89 M(-16.0%) |
| June 2016 | - | $11.78 M(-2.3%) |
| Mar 2016 | - | $12.06 M(+20.4%) |
| Dec 2015 | $171.77 M(+6.5%) | $10.02 M(+77.5%) |
| Sept 2015 | - | $5.64 M(+0.7%) |
| June 2015 | - | $5.61 M(-3.3%) |
| Mar 2015 | - | $5.80 M(+24.5%) |
| Dec 2014 | $161.32 M(+69.5%) | $4.66 M(-22.7%) |
| Sept 2014 | - | $6.03 M(-6.3%) |
| June 2014 | - | $6.43 M(-5.1%) |
| Mar 2014 | - | $6.77 M(+2.7%) |
| Dec 2013 | $95.19 M | $6.60 M(-10.0%) |
| Sept 2013 | - | $7.33 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $6.97 M(+21.0%) |
| Mar 2013 | - | $5.76 M(+40.4%) |
| Dec 2012 | $130.63 M(+104.1%) | $4.10 M(+73.5%) |
| Sept 2012 | - | $2.36 M(+17.2%) |
| June 2012 | - | $2.02 M(-6.3%) |
| Mar 2012 | - | $2.15 M(+21.6%) |
| Dec 2011 | $63.99 M(-28.5%) | $1.77 M(+38.9%) |
| Sept 2011 | - | $1.27 M(-14.8%) |
| June 2011 | - | $1.50 M(-14.1%) |
| Mar 2011 | - | $1.74 M(-5.7%) |
| Dec 2010 | $89.50 M(+20.2%) | $1.85 M(-5.8%) |
| Sept 2010 | - | $1.96 M(-9.3%) |
| June 2010 | - | $2.16 M(-13.1%) |
| Mar 2010 | - | $2.49 M(-8.2%) |
| Dec 2009 | $74.44 M(+0.6%) | $2.71 M(+0.2%) |
| Sept 2009 | - | $2.70 M(+2.1%) |
| June 2009 | - | $2.65 M(-3.6%) |
| Mar 2009 | - | $2.75 M(+7.7%) |
| Dec 2008 | $74.01 M(-26.8%) | $2.55 M(+1.0%) |
| Sept 2008 | - | $2.52 M(+3.4%) |
| June 2008 | - | $2.44 M(+8.4%) |
| Mar 2008 | - | $2.25 M(-1.4%) |
| Dec 2007 | $101.18 M(+121.9%) | $2.28 M(+19.1%) |
| Sept 2007 | - | $1.92 M(+62.1%) |
| June 2007 | - | $1.18 M(+106.8%) |
| Mar 2007 | - | $572.00 K(+14.9%) |
| Dec 2006 | $45.59 M(+126.8%) | $497.80 K(+3.8%) |
| Sept 2006 | - | $479.70 K(+23.5%) |
| June 2006 | - | $388.30 K(-0.4%) |
| Mar 2006 | - | $390.00 K(-3.5%) |
| Dec 2005 | $20.11 M(+24.5%) | $404.10 K(-9.8%) |
| Sept 2005 | - | $448.00 K(+14.3%) |
| June 2005 | - | $392.00 K(+16.5%) |
| Mar 2005 | - | $336.40 K(+30.4%) |
| Dec 2004 | $16.15 M(+3106.0%) | $258.00 K(+47.9%) |
| Sept 2004 | - | $174.40 K(-3.5%) |
| June 2004 | - | $180.80 K(+10.3%) |
| Mar 2004 | - | $163.90 K(+6456.0%) |
| Dec 2003 | $503.60 K(+1829.5%) | - |
| Sept 2003 | - | $2500.00(-44.4%) |
| June 2003 | - | $4500.00(>+9900.0%) |
| Mar 2003 | - | $0.00(-100.0%) |
| Sept 2002 | - | $25.00 K(0.0%) |
| June 2002 | - | $25.00 K(>+9900.0%) |
| Mar 2002 | - | $0.00 |
| Dec 2001 | $26.10 K | - |
FAQ
- What is Halozyme Therapeutics annual long term assets?
- What is the all time high annual non current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual non current assets year-on-year change?
- What is Halozyme Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly non current assets year-on-year change?
What is Halozyme Therapeutics annual long term assets?
The current annual non current assets of HALO is $986.85 M
What is the all time high annual non current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual long term assets is $1.10 B
What is Halozyme Therapeutics annual non current assets year-on-year change?
Over the past year, HALO annual long term assets has changed by -$115.65 M (-10.49%)
What is Halozyme Therapeutics quarterly long term assets?
The current quarterly non current assets of HALO is $991.05 M
What is the all time high quarterly non current assets for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly long term assets is $1.24 B
What is Halozyme Therapeutics quarterly non current assets year-on-year change?
Over the past year, HALO quarterly long term assets has changed by -$22.60 M (-2.23%)